XML 43 R23.htm IDEA: XBRL DOCUMENT
v3.26.1

Restatement of Previously Issued Audited Financial Statements | 12 Months Ended
--- | ---
Dec. 31, 2025
Restatement of Previously Issued Audited Financial Statements [Abstract] |
Restatement of Previously Issued Audited Financial Statements | 15. Restatement of Previously Issued Audited Financial Statements The Company restated its previously reported financial statements for each of the period ended December 31, 2024. The adjustment resulted in an increase to warrant liability by $12.7 million, a decrease in equity balance by $12.7 million and an adjustment from operating activities to financing activities on the statement of cash flow as of December 31, 2024. The Company recognized a loss on the issuance of the Warrants of approximately $2.3 million and offering-related issuance costs of approximately $1.7 million as of December 31, 2024. The tables below set forth the effect on the various financial statement captions including the balances originally reported and the restated balances as of December 31, 2024.
Balance Sheet |  | As Previously Reported |  |  | Adjustments |  |  | As Restated |
Warrant liability |  |  | 15,012,361 |  |  |  | 12,691,566 |  |  |  | 27,703,927 |
Total liabilities |  |  | 18,501,699 |  |  |  | 12,641,566 |  |  |  | 31,143,265 |
Additional paid-in capital |  |  | 200,863,551 |  |  |  | (8,558,271 | ) |  |  | 192,305,280 |
Accumulated deficits |  |  | (189,269,903 | ) |  |  | (4,083,295 | ) |  |  | (193,353,198 | )
Total stockholders’ equity (deficit) |  |  | 11,593,650 |  |  |  | (12,641,566 | ) |  |  | (1,047,916 | )
Statement of Operations |  | As Previously Reported |  |  | Adjustments |  |  | As Restated |
Warrant liability issuance costs |  |  | 0 |  |  |  | (1,739,148 | ) |  |  | (1,739,148 | )
Loss on issuance of warrants |  |  | 0 |  |  |  | (2,344,147 | ) |  |  | (2,344,147 | )
Total other income (expenses), net |  |  | (6,424,209 | ) |  |  | (4,083,295 | ) |  |  | (10,507,504 | )
Net loss |  |  | (29,252,284 | ) |  |  | (4,083,295 | ) |  |  | (33,335,579 | )
Net loss per share attributable to common stockholders, basic and diluted |  |  | (2,212.56 | ) |  |  | (308.85 | ) |  |  | (2,521.41 | )
Statement of Stockholders’ Equity (Deficit) |  | As Previously Reported |  |  | Adjustments |  |  | As Restated |
Issuance of common stock and pre-funded warrants and exercise of pre-funded warrants in connection with the private and public offerings |  |  | 20,972,722 |  |  |  | (8,558,270 | ) |  |  | 12,414,453 |
Net loss |  |  | (29,252,284 | ) |  |  | (4,083,295 | ) |  |  | (33,335,579 | )
Statement of Cash Flows |  | As Previously Reported |  |  | Adjustments |  |  | As Restated |
Net loss |  |  | (29,252,284 | ) |  |  | (4,083,295 | ) |  |  | (33,335,579 | )
Loss on issuance of warrants |  |  | 0 |  |  |  | 2,344,147 |  |  |  | 2,344,147 |
Warrant issuance costs |  |  | 0 |  |  |  | 1,739,148 |  |  |  | 1,739,148 |
Accrued expenses, lease liabilities, and other current liabilities |  |  | 10,642,938 |  |  |  | (9,652,581 | ) |  |  | 990,357 |
Net cash used in operating activities |  |  | 9,493,500 |  |  |  | 9,702,581 |  |  |  | 19,196,081 |
Proceeds from public issuance of common stock and pre-funded warrants and exercise of pre-funded warrants |  |  | 22,369,285 |  |  |  | (8,558,271 | ) |  |  | 13,811,014 |
Proceeds from issuance of warrants |  |  | 0 |  |  |  | 18,260,852 |  |  |  | 18,260,852 |
Net cash provided by financing activities |  |  | 26,584,380 |  |  |  | 9,702,581 |  |  |  | 36,286,961 |
Following this review, the Company completed a comprehensive review of its previously issued financial statements. The Company is adjusting for certain out-of-period errors that were not material, individually or in the aggregate, and are being corrected as part of the restatement. The Company corrected a duplicate bill of $50,000 for issuance costs on an equity transaction, resulting in a decrease in accounts payable and an increase in additional paid-in-capital. The Company also corrected for an immaterial reallocation of proceeds from equity issuances among common stock, common warrants, and pre-funded warrants, related to a previous issuance in 2022, resulting in a reclassification within additional paid-in-capital sub-accounts of $88,024. This correction has no impact on total additional paid-in-capital, net loss, or total stockholders’ equity. The Company believes the adjustments were not material to any prior period, individually or in the aggregate.
Balance Sheet |  | As Previously Reported |  |  | Adjustments |  |  | As Restated |
Accounts Payable |  |  | 297,778 |  |  |  | (50,000 | ) |  |  | 247,778 |
Statement of Cash Flows |  | As Previously Reported |  |  | Adjustments |  |  | As Restated |
Accounts Payable |  |  | 100,815 |  |  |  | (50,000 | ) |  |  | 50,815 |

X
- Definition The entire disclosure of previously issued interim financial statements. + References No definition available. + Details
Name: | cyngn_RestatementOfPreviouslyIssuedInterimFinancialStatementsTextBlock
Namespace Prefix: | cyngn_
Data Type: | dtr:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_AccountingChangesAndErrorCorrectionsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration